Selected research
Industry Research
Zofenopril Industry Research Report 2026
Market perspective
The global Zofenopril market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Zofenopril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Zofenopril is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Zofenopril is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Zofenopril include 2A PharmaChem, 3B Scientific, Advanced Synthesis Technologies, Alfa Chemistry, City Chemicals, Kanto Chemical, Nacalai Tesque, Pfaltz & Bauer and Wako Pure Chemical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Zofenopril market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Zofenopril Market by Company
2A PharmaChem
3B Scientific
Advanced Synthesis Technologies
Alfa Chemistry
City Chemicals
Kanto Chemical
Nacalai Tesque
Pfaltz & Bauer
Wako Pure Chemical Industries
Waterstone Technology
Lifecare Laboratories
LiangXiu Biotechnology
Zofenopril Segment by Type
Purity 98%
Purity 99%
Others
Zofenopril Segment by Application
Chemical Industry
Pharmaceutical Industry
Zofenopril Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zofenopril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zofenopril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zofenopril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Zofenopril manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Zofenopril by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Zofenopril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98%
- Purity 99%
- Others
Applications
- Chemical Industry
- Pharmaceutical Industry
Companies covered
- 2A PharmaChem
- 3B Scientific
- Advanced Synthesis Technologies
- Alfa Chemistry
- City Chemicals
- Kanto Chemical
- Nacalai Tesque
- Pfaltz & Bauer
- Wako Pure Chemical Industries
- Waterstone Technology
- Lifecare Laboratories
- LiangXiu Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Zofenopril Market Size (2021-2032)
- 2.2.2 Global Zofenopril Sales (2021-2032)
- 2.2.3 Global Zofenopril Market Average Price (2021-2032)
- 2.3 Zofenopril by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 98%
- 2.3.3 Purity 99%
- 2.3.4 Others
- 2.4 Zofenopril by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Chemical Industry
- 2.4.3 Pharmaceutical Industry
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Zofenopril Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Zofenopril Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Zofenopril Revenue of Manufacturers (2021-2026)
- 3.4 Global Zofenopril Average Price by Manufacturers (2021-2026)
- 3.5 Global Zofenopril Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Zofenopril, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Zofenopril, Product Type & Application
- 3.8 Global Manufacturers of Zofenopril, Established Date
- 3.9 Global Zofenopril Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 2A PharmaChem
- 4.1.1 2A PharmaChem Company Information
- 4.1.2 2A PharmaChem Business Overview
- 4.1.3 2A PharmaChem Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 2A PharmaChem Zofenopril Product Portfolio
- 4.1.5 2A PharmaChem Recent Developments
- 4.2 3B Scientific
- 4.2.1 3B Scientific Company Information
- 4.2.2 3B Scientific Business Overview
- 4.2.3 3B Scientific Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 3B Scientific Zofenopril Product Portfolio
- 4.2.5 3B Scientific Recent Developments
- 4.3 Advanced Synthesis Technologies
- 4.3.1 Advanced Synthesis Technologies Company Information
- 4.3.2 Advanced Synthesis Technologies Business Overview
- 4.3.3 Advanced Synthesis Technologies Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Advanced Synthesis Technologies Zofenopril Product Portfolio
- 4.3.5 Advanced Synthesis Technologies Recent Developments
- 4.4 Alfa Chemistry
- 4.4.1 Alfa Chemistry Company Information
- 4.4.2 Alfa Chemistry Business Overview
- 4.4.3 Alfa Chemistry Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Alfa Chemistry Zofenopril Product Portfolio
- 4.4.5 Alfa Chemistry Recent Developments
- 4.5 City Chemicals
- 4.5.1 City Chemicals Company Information
- 4.5.2 City Chemicals Business Overview
- 4.5.3 City Chemicals Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 City Chemicals Zofenopril Product Portfolio
- 4.5.5 City Chemicals Recent Developments
- 4.6 Kanto Chemical
- 4.6.1 Kanto Chemical Company Information
- 4.6.2 Kanto Chemical Business Overview
- 4.6.3 Kanto Chemical Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Kanto Chemical Zofenopril Product Portfolio
- 4.6.5 Kanto Chemical Recent Developments
- 4.7 Nacalai Tesque
- 4.7.1 Nacalai Tesque Company Information
- 4.7.2 Nacalai Tesque Business Overview
- 4.7.3 Nacalai Tesque Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nacalai Tesque Zofenopril Product Portfolio
- 4.7.5 Nacalai Tesque Recent Developments
- 4.8 Pfaltz & Bauer
- 4.8.1 Pfaltz & Bauer Company Information
- 4.8.2 Pfaltz & Bauer Business Overview
- 4.8.3 Pfaltz & Bauer Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfaltz & Bauer Zofenopril Product Portfolio
- 4.8.5 Pfaltz & Bauer Recent Developments
- 4.9 Wako Pure Chemical Industries
- 4.9.1 Wako Pure Chemical Industries Company Information
- 4.9.2 Wako Pure Chemical Industries Business Overview
- 4.9.3 Wako Pure Chemical Industries Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wako Pure Chemical Industries Zofenopril Product Portfolio
- 4.9.5 Wako Pure Chemical Industries Recent Developments
- 4.10 Waterstone Technology
- 4.10.1 Waterstone Technology Company Information
- 4.10.2 Waterstone Technology Business Overview
- 4.10.3 Waterstone Technology Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Waterstone Technology Zofenopril Product Portfolio
- 4.10.5 Waterstone Technology Recent Developments
- 4.11 Lifecare Laboratories
- 4.11.1 Lifecare Laboratories Company Information
- 4.11.2 Lifecare Laboratories Business Overview
- 4.11.3 Lifecare Laboratories Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lifecare Laboratories Zofenopril Product Portfolio
- 4.11.5 Lifecare Laboratories Recent Developments
- 4.12 LiangXiu Biotechnology
- 4.12.1 LiangXiu Biotechnology Company Information
- 4.12.2 LiangXiu Biotechnology Business Overview
- 4.12.3 LiangXiu Biotechnology Zofenopril Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 LiangXiu Biotechnology Zofenopril Product Portfolio
- 4.12.5 LiangXiu Biotechnology Recent Developments
5 Global Zofenopril Market Scenario by Region
- 5.1 Global Zofenopril Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Zofenopril Sales by Region: 2021-2032
- 5.2.1 Global Zofenopril Sales by Region: 2021-2026
- 5.2.2 Global Zofenopril Sales by Region: 2027-2032
- 5.3 Global Zofenopril Revenue by Region: 2021-2032
- 5.3.1 Global Zofenopril Revenue by Region: 2021-2026
- 5.3.2 Global Zofenopril Revenue by Region: 2027-2032
- 5.4 North America Zofenopril Market Facts & Figures by Country
- 5.4.1 North America Zofenopril Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Zofenopril Sales by Country (2021-2032)
- 5.4.3 North America Zofenopril Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Zofenopril Market Facts & Figures by Country
- 5.5.1 Europe Zofenopril Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Zofenopril Sales by Country (2021-2032)
- 5.5.3 Europe Zofenopril Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Zofenopril Market Facts & Figures by Country
- 5.6.1 Asia Pacific Zofenopril Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Zofenopril Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Zofenopril Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Zofenopril Market Facts & Figures by Country
- 5.7.1 South America Zofenopril Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Zofenopril Sales by Country (2021-2032)
- 5.7.3 South America Zofenopril Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Zofenopril Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Zofenopril Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Zofenopril Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Zofenopril Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Zofenopril Sales by Type (2021-2032)
- 6.1.1 Global Zofenopril Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Zofenopril Sales Market Share by Type (2021-2032)
- 6.2 Global Zofenopril Revenue by Type (2021-2032)
- 6.2.1 Global Zofenopril Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Zofenopril Revenue Market Share by Type (2021-2032)
- 6.3 Global Zofenopril Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Zofenopril Sales by Application (2021-2032)
- 7.1.1 Global Zofenopril Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Zofenopril Sales Market Share by Application (2021-2032)
- 7.2 Global Zofenopril Revenue by Application (2021-2032)
- 7.2.1 Global Zofenopril Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Zofenopril Revenue Market Share by Application (2021-2032)
- 7.3 Global Zofenopril Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Zofenopril Value Chain Analysis
- 8.1.1 Zofenopril Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Zofenopril Production Mode & Process
- 8.2 Zofenopril Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Zofenopril Distributors
- 8.2.3 Zofenopril Customers
9 Global Zofenopril Analyzing Market Dynamics
- 9.1 Zofenopril Industry Trends
- 9.2 Zofenopril Industry Drivers
- 9.3 Zofenopril Industry Opportunities and Challenges
- 9.4 Zofenopril Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst